Corporate
Board and Management
Mr. Sam Di-Giacomo



| Mr. Sam Di-Giacomo |
|
|
|
Non Executive DirectorMr. Di-Giacomo brings a considerable business background to the company. He has been involved in numerous capital raisings at all stages from seed to IPO and has been involved in a number of technology and distribution licensing deals. He has experience in international expansion including capital markets initiatives; Australian and international listings and capital raisings (NASDAQ and the LSE) and the capture of new intellectual property. He is a founder member of a number of Australian Life Science companies including sPimedica Ltd, Australian Cancer Technology (now Avantogen), Resonance Health, and founding director of Advance Healthcare Group. Mr. Di-Giacomo is also currently a director of the following ASX Listed Companies: Costarella Design Limited(ASX:CLD) and Rokeby Biomed Limited(ASX:RBY). Mr. Di-Giacomo is an Associate Member of the Institute of Chartered Accountants in Australia (ACA) and Securities Institute of Australia (ASIA). He is a fellow of the Australian Institute of Management and is a Certified Practicing Accountant (CPA). |
| < Prev | Next > |
|---|